The broader market closed relatively flat on July 22, 2026, with the S&P 500 slipping 0.14% and the Nasdaq Composite easing 0.57% as climbing oil prices and geopolitical tensions capped index-level gains. Despite this calm surface, individual equities experienced violent repricing as investors aggressively rotated capital, weighing the massive capital expenditures of the artificial intelligence boom against macroeconomic anxieties and shifting consumer habits.
The AI Infrastructure and Power Boom
Hardware assemblers and energy providers exposed to data center growth saw aggressive buying as the market rewarded tangible AI monetization. SMCI (+19.84%) ignited a hardware rally after doubling its Q4 gross margin guidance to 15%–17% and revealing a staggering $60 billion AI server order backlog. This structural profitability leap shattered lingering commoditization fears, immediately pulling DELL (+9.32%) higher as institutions positioned for its own $51.3 billion AI backlog.
The secondary beneficiaries of this server build-out—energy and infrastructure—also posted robust gains. EQT (+8.45%) surged after achieving a rare operational double: raising full-year production guidance by 90 Bcfe while cutting its capital expenditure budget by $25 million, heavily supported by new data center and LNG supply deals. Similarly, NRG (+6.37%) jumped on heightened optimism for Texas AI infrastructure, lucrative PJM capacity auction results, and a new quarterly dividend. However, not all power players were rewarded. GEV (-8.69%) plummeted as a Q2 EPS miss and widening losses in its legacy Wind segment overshadowed an 88% surge in organic orders tied to AI power demand, proving that premium valuations demand flawless execution across all business units.
Software Repricing and the "SaaSpocalypse"
While hardware soared, enterprise software faced a brutal contraction as the market priced in fears that AI infrastructure spending is actively cannibalizing traditional software-as-a-service (SaaS) budgets. WDAY (-6.20%) suffered a severe sell-off following a Morgan Stanley downgrade highlighting exactly this dynamic, shifting the stock from a growth premium to a "show-me" story. PTC (-6.34%) faced similar pre-earnings de-risking as fears mount over AI disrupting seat-based licensing models.
NOW (-6.47%) was caught in the regular-session contagion—exacerbated by OpenAI's enterprise "Presence" launch—before rebounding more than 5% in after-hours trading when its Q2 print revealed AI annual contract value had surpassed $1 billion. In the data analytics space, PLTR (-6.10%) rejected technical resistance at $130, weighed down by UK regulatory scrutiny of its NHS contract and a newly launched open-source competitor. Meanwhile, SNPS (-11.21%) suffered a steep drawdown driven by macroeconomic China export control fears and the near-term revenue uncertainty of phasing out its legacy factory software.
Healthcare Volatility and Biotech Contagion
The healthcare sector saw deep divergence driven by earnings clustering and sector contagion. MRNA (-14.95%) was caught in a perfect storm, dragged down by weak bioprocessing results from life sciences peer Danaher, fresh mRNA patent litigation, and pre-catalyst profit taking. ISRG (-12.41%) delivered a Q2 earnings beat but suffered violent multiple compression after management warned of slowing US surgical procedure growth and upcoming margin pressure. Conversely, ABT (+12.66%) enjoyed a powerful sentiment reset, successfully pivoting the narrative away from infant formula litigation by demonstrating rapid top-line synergies from its recent Exact Sciences acquisition.
Industrial Standouts and Consumer Drags
Outside the technology and healthcare clusters, traditional industrials delivered some of the session's strongest fundamental surprises. TRV (+13.03%) sparked a massive short squeeze by posting Q2 Core EPS of $10.04 against a $5.41 expectation, driven by falling catastrophe losses and pristine underwriting. In the UK, DPLM.L (+12.04%) surged on a blockbuster Q3 update featuring 15% organic growth and a massive FY26 margin guidance raise. WAB (+10.04%) hit fresh all-time highs after raising full-year guidance on the back of a record $30.93 billion rail backlog.
Elsewhere, consumer and legacy platforms faltered under structural headwinds. STJ.L (-11.30%) plummeted amid a partner exodus to a Swedish consolidator and a Barclays downgrade over AI wealth platform threats. GLW (-11.67%) suffered a sharp valuation reset driven by tempered telecom carrier spending and massive insider sales. Finally, both COIN (-5.53%) and DASH (-5.48%) retreated on shifting macro currents. Coinbase was pressured by dropping regulatory CLARITY Act odds and falling trading volumes, while DoorDash succumbed to cautious consumer spending guidance, gig economy margin fears, and competitive reshuffling following Uber's Delivery Hero deal.
What to Watch
- July 28: Corning (GLW) Q2 earnings.
- July 29: St. James's Place (STJ.L) Q2 print and PTC Inc (PTC) fiscal Q3 earnings.
- July 30: Coinbase (COIN) Q2 earnings.
- July 31: Moderna (MRNA) Q2 earnings.
- August 3: Palantir (PLTR) Q2 earnings.
- August 5: DoorDash (DASH) earnings and Moderna's (MRNA) seasonal flu vaccine FDA PDUFA decision.